Payment overview · 2025
General Payments
$655.34
27 reported records · 9 companies
Healthcare provider profile · identity verified
Susan S Lowry, MD
Allopathic & Osteopathic Physicians|Family Medicine · MARTIN, TN · NPI 1871592287
Verified facts
What the public records show
CMS Open Payments records show Susan S Lowry, MD received $655.34 in general payments during 2025 across 27 reported records.
Novo Nordisk Inc accounted for 32.1% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 12 associated products.
A separate comparison found the same explicitly named product in public Medicare Part D data: Farxiga, Ozempic, Rexulti, Rybelsus.
AstraZeneca Pharmaceuticals LP reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported BRILINTA as an associated drug or biological on 993 records involving 512 distinct recipient NPIs. Public Medicare Part D data also shows 20 claims for Brilinta by this doctor in 2024.
AstraZeneca Pharmaceuticals LP reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported FARXIGA as an associated drug or biological on 106133 records involving 42906 distinct recipient NPIs. Public Medicare Part D data also shows 134 claims for Farxiga by this doctor in 2024.
AstraZeneca Pharmaceuticals LP reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported SYMBICORT as an associated drug or biological on 71 records involving 51 distinct recipient NPIs. Public Medicare Part D data also shows 53 claims for Symbicort by this doctor in 2024.
Lilly USA, LLC reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported JARDIANCE as an associated drug or biological on 47708 records involving 23833 distinct recipient NPIs. Public Medicare Part D data also shows 267 claims for Jardiance by this doctor in 2024.
Lilly USA, LLC reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported MOUNJARO as an associated drug or biological on 186719 records involving 66436 distinct recipient NPIs. Public Medicare Part D data also shows 60 claims for Mounjaro by this doctor in 2024.
Lilly USA, LLC reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported TRULICITY as an associated drug or biological on 71 records involving 57 distinct recipient NPIs. Public Medicare Part D data also shows 58 claims for Trulicity by this doctor in 2024.
Novo Nordisk Inc reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported Ozempic as an associated drug or biological on 261625 records involving 77793 distinct recipient NPIs. Public Medicare Part D data also shows 207 claims for Ozempic by this doctor in 2024.
Novo Nordisk Inc reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported Rybelsus as an associated drug or biological on 161257 records involving 55409 distinct recipient NPIs. Public Medicare Part D data also shows 87 claims for Rybelsus by this doctor in 2024.
Otsuka America Pharmaceutical, Inc. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported REXULTI as an associated drug or biological on 160756 records involving 46288 distinct recipient NPIs. Public Medicare Part D data also shows 78 claims for Rexulti by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Novo Nordisk Inc | Unresolved — no canonical attribution shown | $210.47 | 32.1% | 7 | 2025 |
| AstraZeneca Pharmaceuticals LP | Unresolved — no canonical attribution shown | $116.18 | 17.7% | 5 | 2025 |
| Otsuka America Pharmaceutical, Inc. | Unresolved — no canonical attribution shown | $111.15 | 17.0% | 6 | 2025 |
| Exact Sciences Corporation | Unresolved — no canonical attribution shown | $62.62 | 9.6% | 3 | 2025 |
| Dexcom, Inc. | Unresolved — no canonical attribution shown | $50.48 | 7.7% | 2 | 2025 |
| Lilly USA, LLC | Unresolved — no canonical attribution shown | $45.00 | 6.9% | 1 | 2025 |
| Verona Pharma, Inc. | Unresolved — no canonical attribution shown | $24.48 | 3.7% | 1 | 2025 |
| Seqirus USA Inc | Unresolved — no canonical attribution shown | $19.60 | 3.0% | 1 | 2025 |
| Baxter Healthcare | Unresolved — no canonical attribution shown | $15.36 | 2.3% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $610.34 | 26 |
| Education | $45.00 | 1 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| Ozempic Normalized: ozempic |
Drug | Novo Nordisk Inc | $210.47 | 7 | 2025 |
Source payment records
|
|||||
| REXULTI Normalized: rexulti |
Drug | Otsuka America Pharmaceutical, Inc. | $111.15 | 6 | 2025 |
Source payment records
|
|||||
| FARXIGA Normalized: farxiga |
Drug | AstraZeneca Pharmaceuticals LP | $77.82 | 3 | 2025 |
Source payment records
|
|||||
| Cologuard Collection Kit Normalized: cologuard collection kit |
Device | Exact Sciences Corporation | $62.62 | 3 | 2025 |
Source payment records
|
|||||
| Dexcom G6 Transmitter Normalized: dexcom g6 transmitter |
Medical Supply | Dexcom, Inc. | $50.48 | 2 | 2025 |
Source payment records
|
|||||
| Rybelsus Normalized: rybelsus |
Drug | Novo Nordisk Inc | $44.43 | 2 | 2025 |
Source payment records
|
|||||
| Ohtuvayre Normalized: ohtuvayre |
Drug | Verona Pharma, Inc. | $24.48 | 1 | 2025 |
Source payment records
|
|||||
| BREZTRI Normalized: breztri |
Drug | AstraZeneca Pharmaceuticals LP | $20.58 | 1 | 2025 |
Source payment records
|
|||||
| Fluad Normalized: fluad |
Biological | Seqirus USA Inc | $19.60 | 1 | 2025 |
Source payment records
|
|||||
| Flucelvax Normalized: flucelvax |
Biological | Seqirus USA Inc | $19.60 | 1 | 2025 |
Source payment records
|
|||||
| AIRSUPRA Normalized: airsupra |
Drug | AstraZeneca Pharmaceuticals LP | $17.78 | 1 | 2025 |
Source payment records
|
|||||
| Hillrom - Cardiac Ambulatory Monitor Normalized: hillrom cardiac ambulatory monitor |
Device | Baxter Healthcare | $15.36 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
| Open Payments product | Payment year | Part D brand | Part D year | Claims | Match method | Source |
|---|---|---|---|---|---|---|
| FARXIGA farxiga |
2025 | Farxiga | 2024 | 134 | exact normalized | Medicare Part D |
| Ozempic ozempic |
2025 | Ozempic | 2024 | 207 | exact normalized | Medicare Part D |
| REXULTI rexulti |
2025 | Rexulti | 2024 | 78 Beneficiary count suppressed |
exact normalized | Medicare Part D |
| Rybelsus rybelsus |
2025 | Rybelsus | 2024 | 87 | exact normalized | Medicare Part D |
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| AstraZeneca Pharmaceuticals LP Exact reporting entity; no affiliate inference |
2025 | BRILINTA open payments reported associated product |
CMS Open Payments — General Payments 993 supporting records · 512 recipient NPIs · example record 1206131430 |
Brilinta · 2024 Exact normalized brand match · 1 Part D row |
20 | suppressed by CMS |
| AstraZeneca Pharmaceuticals LP Exact reporting entity; no affiliate inference |
2025 | FARXIGA open payments reported associated product |
CMS Open Payments — General Payments 106133 supporting records · 42906 recipient NPIs · example record 1206131362 |
Farxiga · 2024 Exact normalized brand match · 1 Part D row |
134 | 19 |
| AstraZeneca Pharmaceuticals LP Exact reporting entity; no affiliate inference |
2025 | SYMBICORT open payments reported associated product |
CMS Open Payments — General Payments 71 supporting records · 51 recipient NPIs · example record 1206132610 |
Symbicort · 2024 Exact normalized brand match · 1 Part D row |
53 | 12 |
| Lilly USA, LLC Exact reporting entity; no affiliate inference |
2025 | JARDIANCE open payments reported associated product |
CMS Open Payments — General Payments 47708 supporting records · 23833 recipient NPIs · example record 1186464557 |
Jardiance · 2024 Exact normalized brand match · 1 Part D row |
267 | 16 |
| Lilly USA, LLC Exact reporting entity; no affiliate inference |
2025 | MOUNJARO open payments reported associated product |
CMS Open Payments — General Payments 186719 supporting records · 66436 recipient NPIs · example record 1186464455 |
Mounjaro · 2024 Exact normalized brand match · 1 Part D row |
60 | suppressed by CMS |
| Lilly USA, LLC Exact reporting entity; no affiliate inference |
2025 | TRULICITY open payments reported associated product |
CMS Open Payments — General Payments 71 supporting records · 57 recipient NPIs · example record 1186464601 |
Trulicity · 2024 Exact normalized brand match · 1 Part D row |
58 | suppressed by CMS |
| Novo Nordisk Inc Exact reporting entity; no affiliate inference |
2025 | Ozempic open payments reported associated product |
CMS Open Payments — General Payments 261625 supporting records · 77793 recipient NPIs · example record 1188130076 |
Ozempic · 2024 Exact normalized brand match · 1 Part D row |
207 | 36 |
| Novo Nordisk Inc Exact reporting entity; no affiliate inference |
2025 | Rybelsus open payments reported associated product |
CMS Open Payments — General Payments 161257 supporting records · 55409 recipient NPIs · example record 1188130076 |
Rybelsus · 2024 Exact normalized brand match · 1 Part D row |
87 | 13 |
| Otsuka America Pharmaceutical, Inc. Exact reporting entity; no affiliate inference |
2025 | REXULTI open payments reported associated product |
CMS Open Payments — General Payments 160756 supporting records · 46288 recipient NPIs · example record 1227267708 |
Rexulti · 2024 Exact normalized brand match · 1 Part D row |
78 | suppressed by CMS |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 1839 | 218 |
| Furosemide | Furosemide | 1761 | 180 |
| Levothyroxine Sodium | Levothyroxine Sodium | 1708 | 184 |
| Atorvastatin Calcium | Atorvastatin Calcium | 1683 | 183 |
| Pantoprazole Sodium | Pantoprazole Sodium | 1568 | 179 |
| Amlodipine Besylate | Amlodipine Besylate | 1554 | 158 |
| Donepezil Hcl | Donepezil Hcl | 1326 | 59 |
| Potassium Chloride | Potassium Chloride | 1225 | 140 |
| Lisinopril | Lisinopril | 1172 | 128 |
| Sertraline Hcl | Sertraline Hcl | 1123 | 80 |
| Gabapentin | Gabapentin | 981 | 161 |
| Buspirone Hcl | Buspirone Hcl | 914 | 63 |
| Trazodone Hcl | Trazodone Hcl | 906 | 104 |
| Alprazolam | Alprazolam | 887 | 109 |
| Losartan Potassium | Losartan Potassium | 871 | 93 |
| Metoprolol Tartrate | Metoprolol Tartrate | 868 | 87 |
| Divalproex Sodium | Divalproex Sodium | 843 | 55 |
| Oxycodone Hcl | Oxycodone Hcl | 781 | 86 |
| Escitalopram Oxalate | Escitalopram Oxalate | 774 | 84 |
| Famotidine | Famotidine | 754 | 52 |
| Tamsulosin Hcl | Tamsulosin Hcl | 714 | 77 |
| Metoprolol Succinate | Metoprolol Succinate | 712 | 82 |
| Omeprazole | Omeprazole | 706 | 122 |
| Quetiapine Fumarate | Quetiapine Fumarate | 699 | 60 |
| Eliquis | Apixaban | 655 | 53 |
| Mirtazapine | Mirtazapine | 653 | 61 |
| Clopidogrel | Clopidogrel Bisulfate | 618 | 80 |
| Lamotrigine | Lamotrigine | 618 | 27 |
| Citalopram Hbr | Citalopram Hydrobromide | 565 | 58 |
| Memantine Hcl | Memantine Hcl | 564 | 22 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 562 | 88 |
| Metformin Hcl | Metformin Hcl | 538 | 73 |
| Benztropine Mesylate | Benztropine Mesylate | 510 | 18 |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 506 | 57 |
| Baclofen | Baclofen | 489 | 40 |
| Glimepiride | Glimepiride | 488 | 73 |
| Hydrochlorothiazide | Hydrochlorothiazide | 476 | 61 |
| Paroxetine Hcl | Paroxetine Hcl | 460 | 24 |
| Tramadol Hcl | Tramadol Hcl | 453 | 69 |
| Duloxetine Hcl | Duloxetine Hcl | 447 | 47 |
| Hydralazine Hcl | Hydralazine Hcl | 430 | 35 |
| Carvedilol | Carvedilol | 420 | 61 |
| Lorazepam | Lorazepam | 411 | 83 |
| Simvastatin | Simvastatin | 385 | 71 |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 371 | 18 |
| Clonazepam | Clonazepam | 346 | 40 |
| Olanzapine | Olanzapine | 345 | 14 |
| Montelukast Sodium | Montelukast Sodium | 344 | 47 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 327 | 82 |
| Meloxicam | Meloxicam | 322 | 55 |
| Fluoxetine Hcl | Fluoxetine Hcl | 321 | 33 |
| Ropinirole Hcl | Ropinirole Hcl | 315 | 30 |
| Allopurinol | Allopurinol | 314 | 44 |
| Levetiracetam | Levetiracetam | 310 | 22 |
| Risperidone | Risperidone | 310 | 19 |
| Clonidine Hcl | Clonidine Hcl | 292 | 25 |
| Zolpidem Tartrate | Zolpidem Tartrate | 287 | 36 |
| Prednisone | Prednisone | 286 | 89 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 280 | 43 |
| Dextroamphetamine-Amphetamine | Dextroamphetamine/Amphetamine | 271 | 32 |
| Jardiance | Empagliflozin | 267 | 16 |
| Tizanidine Hcl | Tizanidine Hcl | 251 | 43 |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 249 | 21 |
| Ondansetron Hcl | Ondansetron Hcl | 248 | 53 |
| Spironolactone | Spironolactone | 247 | 45 |
| Diazepam | Diazepam | 240 | 32 |
| Promethazine Hcl | Promethazine Hcl | 240 | 61 |
| Propranolol Hcl | Propranolol Hcl | 236 | 20 |
| Oxybutynin Chloride | Oxybutynin Chloride | 230 | 14 |
| Januvia | Sitagliptin Phosphate | 226 | 15 |
| Xarelto | Rivaroxaban | 208 | 22 |
| Ozempic | Semaglutide | 207 | 36 |
| Sucralfate | Sucralfate | 205 | 19 |
| Finasteride | Finasteride | 189 | 11 |
| Pregabalin | Pregabalin | 185 | 30 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 182 | 27 |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 181 | 28 |
| Bupropion Xl | Bupropion Hcl | 176 | 19 |
| Estradiol | Estradiol | 176 | 44 |
| Aripiprazole | Aripiprazole | 174 | 23 |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 174 | 12 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 167 | 36 |
| Pravastatin Sodium | Pravastatin Sodium | 166 | 14 |
| Haloperidol | Haloperidol | 164 | 14 |
| Diclofenac Sodium | Diclofenac Sodium | 161 | 34 |
| Amitriptyline Hcl | Amitriptyline Hcl | 152 | 25 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 152 | 23 |
| Atenolol | Atenolol | 147 | 17 |
| Morphine Sulfate Er | Morphine Sulfate | 144 | 14 |
| Fluticasone Propionate | Fluticasone Propionate | 140 | 49 |
| Glipizide | Glipizide | 140 | 18 |
| Lovastatin | Lovastatin | 138 | suppressed |
| Fluconazole | Fluconazole | 137 | 50 |
| Cephalexin | Cephalexin | 136 | 73 |
| Dexamethasone | Dexamethasone | 135 | 57 |
| Farxiga | Dapagliflozin Propanediol | 134 | 19 |
| Midodrine Hcl | Midodrine Hcl | 132 | 15 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 119 | 17 |
| Lactulose | Lactulose | 118 | 25 |
| Rivastigmine | Rivastigmine Tartrate | 117 | suppressed |
| Digoxin | Digoxin | 116 | suppressed |
| Rivastigmine | Rivastigmine | 114 | suppressed |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 113 | 30 |
| Amoxicillin | Amoxicillin | 112 | 64 |
| Topiramate | Topiramate | 107 | 18 |
| Nifedipine Er | Nifedipine | 106 | suppressed |
| Dicyclomine Hcl | Dicyclomine Hcl | 105 | 13 |
| Ibuprofen | Ibuprofen | 104 | 30 |
| Azithromycin | Azithromycin | 103 | 71 |
| Pioglitazone Hcl | Pioglitazone Hcl | 103 | 15 |
| Amiodarone Hcl | Amiodarone Hcl | 102 | 15 |
| Metformin Hcl Er | Metformin Hcl | 102 | 16 |
| Torsemide | Torsemide | 101 | 22 |
| Lidocaine | Lidocaine | 100 | suppressed |
| Fludrocortisone Acetate | Fludrocortisone Acetate | 97 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 96 | 29 |
| Morphine Sulfate | Morphine Sulfate | 96 | 27 |
| Myrbetriq | Mirabegron | 96 | suppressed |
| Oxcarbazepine | Oxcarbazepine | 95 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 92 | 21 |
| Levofloxacin | Levofloxacin | 91 | 63 |
| Entresto | Sacubitril/Valsartan | 90 | suppressed |
| Medroxyprogesterone Acetate | Medroxyprogesterone Acetate | 90 | suppressed |
| Methocarbamol | Methocarbamol | 90 | suppressed |
| Rybelsus | Semaglutide | 87 | 13 |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 85 | 57 |
| Alendronate Sodium | Alendronate Sodium | 82 | suppressed |
| Ezetimibe | Ezetimibe | 81 | 16 |
| Hydroxychloroquine Sulfate | Hydroxychloroquine Sulfate | 81 | 16 |
| Warfarin Sodium | Warfarin Sodium | 81 | 12 |
| Nystatin | Nystatin | 80 | 47 |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 79 | suppressed |
| Rexulti | Brexpiprazole | 78 | suppressed |
| Ipratropium-Albuterol | Ipratropium/Albuterol Sulfate | 77 | 27 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 77 | 21 |
| Nitrofurantoin | Nitrofurantoin Macrocrystal | 77 | 15 |
| Verapamil Er | Verapamil Hcl | 77 | suppressed |
| Celecoxib | Celecoxib | 76 | 18 |
| Diltiazem 24hr Er | Diltiazem Hcl | 75 | suppressed |
| Phenytoin Sodium Extended | Phenytoin Sodium Extended | 73 | suppressed |
| Testosterone Cypionate | Testosterone Cypionate | 73 | 13 |
| Bisoprolol-Hydrochlorothiazide | Bisoprolol/Hydrochlorothiazide | 72 | 15 |
| Lansoprazole | Lansoprazole | 72 | suppressed |
| Metoclopramide Hcl | Metoclopramide Hcl | 69 | 16 |
| Glipizide Er | Glipizide | 68 | suppressed |
| Bumetanide | Bumetanide | 67 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 67 | suppressed |
| Sevelamer Carbonate | Sevelamer Carbonate | 67 | suppressed |
| Budesonide-Formoterol Fumarate | Budesonide/Formoterol Fumarate | 66 | 16 |
| Latanoprost | Latanoprost | 66 | 11 |
| Galantamine Hbr | Galantamine Hbr | 65 | suppressed |
| Ibandronate Sodium | Ibandronate Sodium | 64 | 21 |
| Ziprasidone Hcl | Ziprasidone Hcl | 61 | suppressed |
| Enalapril Maleate | Enalapril Maleate | 60 | suppressed |
| Mounjaro | Tirzepatide | 60 | suppressed |
| Vitamin D2 | Ergocalciferol (Vitamin D2) | 60 | 15 |
| Trulicity | Dulaglutide | 58 | suppressed |
| Methotrexate | Methotrexate Sodium | 57 | 12 |
| Primidone | Primidone | 56 | suppressed |
| Isosorbide Dinitrate | Isosorbide Dinitrate | 53 | suppressed |
| Novolog | Insulin Aspart | 53 | suppressed |
| Sumatriptan Succinate | Sumatriptan Succinate | 53 | 12 |
| Symbicort | Budesonide/Formoterol Fumarate | 53 | 12 |
| Valproic Acid | Valproic Acid (As Sodium Salt) | 53 | suppressed |
| Nebivolol Hcl | Nebivolol Hcl | 52 | suppressed |
| Savella | Milnacipran Hcl | 51 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 50 | 11 |
| Theophylline Er | Theophylline Anhydrous | 50 | 11 |
| Ondansetron Odt | Ondansetron | 49 | 16 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 49 | 23 |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 48 | 11 |
| Combivent Respimat | Ipratropium/Albuterol Sulfate | 47 | 18 |
| Colchicine | Colchicine | 46 | suppressed |
| Cefdinir | Cefdinir | 44 | 29 |
| Cholestyramine Light | Cholestyramine | 44 | suppressed |
| Doxepin Hcl | Doxepin Hcl | 43 | suppressed |
| Cyproheptadine Hcl | Cyproheptadine Hcl | 42 | suppressed |
| Fluvoxamine Maleate | Fluvoxamine Maleate | 42 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 41 | 34 |
| Buprenorphine-Naloxone | Buprenorphine Hcl/Naloxone Hcl | 41 | suppressed |
| Tresiba Flextouch U-200 | Insulin Degludec | 41 | suppressed |
| Dapagliflozin | Dapagliflozin Propanediol | 39 | suppressed |
| Linzess | Linaclotide | 39 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 39 | 17 |
| Synthroid | Levothyroxine Sodium | 39 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 38 | 26 |
| Butalbital-Acetaminophen-Caffe | Butalb/Acetaminophen/Caffeine | 37 | suppressed |
| Pentoxifylline | Pentoxifylline | 37 | suppressed |
| Bisoprolol Fumarate | Bisoprolol Fumarate | 35 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 35 | suppressed |
| Fentanyl | Fentanyl | 34 | suppressed |
| Irbesartan | Irbesartan | 34 | suppressed |
| Metronidazole | Metronidazole | 34 | 24 |
| Ultra-Fine Mini Pen Needle | Pen Needle, Diabetic | 34 | 12 |
| Dutasteride | Dutasteride | 33 | suppressed |
| Humalog Kwikpen U-100 | Insulin Lispro | 33 | suppressed |
| Nano 2nd Gen Pen Needle | Pen Needle, Diabetic | 33 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 33 | 21 |
| Carisoprodol | Carisoprodol | 32 | suppressed |
| Lamotrigine Er | Lamotrigine | 32 | suppressed |
| Lidocaine Hcl | Lidocaine Hcl | 32 | 22 |
| Memantine Hcl Er | Memantine Hcl | 32 | suppressed |
| Methylphenidate Hcl | Methylphenidate Hcl | 32 | suppressed |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 31 | suppressed |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 30 | suppressed |
| Novolog Mix 70-30 Flexpen | Insulin Aspart Prot/Insuln Asp | 30 | suppressed |
| Testosterone | Testosterone | 30 | suppressed |
| Budesonide | Budesonide | 29 | suppressed |
| Gemfibrozil | Gemfibrozil | 28 | suppressed |
| Nitroglycerin | Nitroglycerin | 28 | 18 |
| Acyclovir | Acyclovir | 27 | 13 |
| Breo Ellipta | Fluticasone/Vilanterol | 27 | suppressed |
| Lacosamide | Lacosamide | 27 | suppressed |
| Albuterol Sulfate | Albuterol Sulfate | 26 | suppressed |
| Butorphanol Tartrate | Butorphanol Tartrate | 26 | suppressed |
| Nystop | Nystatin | 26 | 16 |
| Ceftriaxone | Ceftriaxone Sodium | 25 | 21 |
| Toujeo Solostar | Insulin Glargine,hum.Rec.Anlog | 25 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 24 | 11 |
| Hydrocortisone | Hydrocortisone | 24 | suppressed |
| Lurasidone Hcl | Lurasidone Hcl | 24 | suppressed |
| Anoro Ellipta | Umeclidinium Brm/Vilanterol Tr | 23 | suppressed |
| Aspirin-Dipyridamole Er | Aspirin/Dipyridamole | 23 | suppressed |
| Cilostazol | Cilostazol | 23 | suppressed |
| Diltiazem Hcl | Diltiazem Hcl | 23 | suppressed |
| Felodipine Er | Felodipine | 23 | suppressed |
| Hydroxyzine Pamoate | Hydroxyzine Pamoate | 23 | suppressed |
| Klor-Con M20 | Potassium Chloride | 23 | suppressed |
| Naproxen | Naproxen | 23 | suppressed |
| Valsartan | Valsartan | 23 | suppressed |
| Vraylar | Cariprazine Hcl | 23 | suppressed |
| Zenpep | Lipase/Protease/Amylase | 23 | suppressed |
| Haloperidol Decanoate | Haloperidol Decanoate | 22 | suppressed |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 22 | suppressed |
| Amantadine | Amantadine Hcl | 21 | suppressed |
| Clindamycin Hcl | Clindamycin Hcl | 21 | 13 |
| Janumet Xr | Sitagliptin Phos/Metformin Hcl | 21 | suppressed |
| Levemir Flexpen | Insulin Detemir | 21 | suppressed |
| Lubiprostone | Lubiprostone | 21 | suppressed |
| Tramadol Hcl-Acetaminophen | Tramadol Hcl/Acetaminophen | 21 | suppressed |
| Acetaminophen-Codeine | Acetaminophen With Codeine | 20 | suppressed |
| Brilinta | Ticagrelor | 20 | suppressed |
| Daptomycin | Daptomycin | 20 | suppressed |
| Dexlansoprazole Dr | Dexlansoprazole | 20 | suppressed |
| Methylprednisolone | Methylprednisolone | 20 | 16 |
| Metolazone | Metolazone | 20 | suppressed |
| Paliperidone Er | Paliperidone | 20 | suppressed |
| Venlafaxine Hcl | Venlafaxine Hcl | 20 | suppressed |
| Bupropion Hcl | Bupropion Hcl | 19 | suppressed |
| Divalproex Sodium Er | Divalproex Sodium | 19 | suppressed |
| Fenofibrate | Fenofibrate | 19 | suppressed |
| Fycompa | Perampanel | 19 | suppressed |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 19 | suppressed |
| Shingrix | Varicella-Zoster Ge/As01b/Pf | 19 | 18 |
| Trintellix | Vortioxetine Hydrobromide | 19 | suppressed |
| Xtampza Er | Oxycodone Myristate | 19 | suppressed |
| Desvenlafaxine Succinate Er | Desvenlafaxine Succinate | 18 | suppressed |
| Diphenoxylate-Atropine | Diphenoxylate Hcl/Atropine | 18 | suppressed |
| Glyburide | Glyburide | 18 | suppressed |
| Ingrezza | Valbenazine Tosylate | 18 | suppressed |
| Isosorbide Mononitrate | Isosorbide Mononitrate | 18 | suppressed |
| Mupirocin | Mupirocin | 18 | suppressed |
| Rizatriptan | Rizatriptan Benzoate | 18 | suppressed |
| Stiolto Respimat | Tiotropium Br/Olodaterol Hcl | 18 | suppressed |
| Tiotropium Bromide | Tiotropium Bromide | 18 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 18 | suppressed |
| Breztri Aerosphere | Budesonide/Glycopyr/Formoterol | 17 | suppressed |
| Dextroamphetamine-Amphet Er | Dextroamphetamine/Amphetamine | 17 | suppressed |
| Humulin 70-30 | Insulin Nph Hum/Reg Insulin Hm | 17 | suppressed |
| Janumet | Sitagliptin Phos/Metformin Hcl | 17 | suppressed |
| Terbinafine Hcl | Terbinafine Hcl | 17 | suppressed |
| Benazepril Hcl | Benazepril Hcl | 16 | suppressed |
| Dorzolamide-Timolol | Dorzolamide Hcl/Timolol Maleat | 16 | suppressed |
| Ketorolac Tromethamine | Ketorolac Tromethamine | 16 | suppressed |
| Lithium Carbonate | Lithium Carbonate | 16 | suppressed |
| Tobramycin-Dexamethasone | Tobramycin/Dexamethasone | 16 | suppressed |
| Ulticare Pen Needle | Pen Needle, Diabetic | 16 | suppressed |
| Calcium Acetate | Calcium Acetate | 15 | suppressed |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 15 | suppressed |
| Novolin N Flexpen | Insulin Nph Human Isophane | 15 | suppressed |
| Novolog Flexpen | Insulin Aspart | 15 | suppressed |
| Nyamyc | Nystatin | 15 | suppressed |
| Ranolazine Er | Ranolazine | 15 | suppressed |
| Doxycycline Monohydrate | Doxycycline Monohydrate | 14 | suppressed |
| Humalog | Insulin Lispro | 14 | suppressed |
| Levemir | Insulin Detemir | 14 | suppressed |
| Loperamide | Loperamide Hcl | 14 | suppressed |
| Premarin | Estrogens, Conjugated | 14 | suppressed |
| Spiriva Handihaler | Tiotropium Bromide | 14 | suppressed |
| Tresiba Flextouch U-100 | Insulin Degludec | 14 | suppressed |
| Trihexyphenidyl Hcl | Trihexyphenidyl Hcl | 14 | suppressed |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 13 | suppressed |
| Glipizide-Metformin | Glipizide/Metformin Hcl | 13 | suppressed |
| Humira(Cf) | Adalimumab | 13 | suppressed |
| Invokana | Canagliflozin | 13 | suppressed |
| Ondansetron Hcl | Ondansetron Hcl/Pf | 13 | suppressed |
| Terazosin Hcl | Terazosin Hcl | 13 | suppressed |
| Thyroid | Thyroid,pork | 13 | suppressed |
| Cefadroxil | Cefadroxil | 12 | suppressed |
| Humira | Adalimumab | 12 | suppressed |
| Humira(Cf) Pen | Adalimumab | 12 | suppressed |
| Lidocaine Hcl | Lidocaine Hcl/Pf | 12 | suppressed |
| Olmesartan-Hydrochlorothiazide | Olmesartan/Hydrochlorothiazide | 12 | suppressed |
| Oxycontin | Oxycodone Hcl | 12 | suppressed |
| Tolterodine Tartrate Er | Tolterodine Tartrate | 12 | suppressed |
| Velphoro | Sucroferric Oxyhydroxide | 12 | suppressed |
| Zolpidem Tartrate Er | Zolpidem Tartrate | 12 | suppressed |
| Carbamazepine Er | Carbamazepine | 11 | suppressed |
| Cartia Xt | Diltiazem Hcl | 11 | suppressed |
| Chlordiazepoxide Hcl | Chlordiazepoxide Hcl | 11 | suppressed |
| Chlorpromazine Hcl | Chlorpromazine Hcl | 11 | suppressed |
| Emgality Pen | Galcanezumab-Gnlm | 11 | suppressed |
| Irbesartan-Hydrochlorothiazide | Irbesartan/Hydrochlorothiazide | 11 | suppressed |
| Movantik | Naloxegol Oxalate | 11 | suppressed |
| Naproxen Sodium | Naproxen Sodium | 11 | suppressed |
| Sure Comfort | Syringe And Needle,insulin,1ml | 11 | suppressed |
| Unifine Safecontrol Pen Needle | Pen Needle,dual Safety,diabetc | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $655.34 · 27 records | Novo Nordisk Inc | AIRSUPRA, BREZTRI, Cologuard Collection Kit, Dexcom G6 Transmitter, FARXIGA, Fluad, Flucelvax, Hillrom - Cardiac Ambulatory Monitor, Ohtuvayre, Ozempic, REXULTI, Rybelsus | 9 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- What role, if any, does Farxiga play in your treatment recommendations for me?
- How do you evaluate evidence when you have a financial relationship with AstraZeneca Pharmaceuticals LP?
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error